Showing all 5 results

Show sidebar

Ala-ala-asn-pab peptide linkers improve physiochemical property and toxicity profiles of cytotoxic drugs by forming a peptide-drug conjugate. The peptide drug conjugate can be cleaved by cellular proteases and release the cytotoxic drugs in their active form.

AxisPharm developed a novel process to synthesize ala-ala-asn-pab and its derivatives in large scale. For custom synthesis please contact us.

Ref: Peptide-prodrug Conjugates by Sam Chu

Catalog# Name Structure M.W. Purity Pricing
Ala-Ala-Asn-pab peptide Linkers
AP10016Fmoc-Ala-Ala-Asn-PAB-PNP766.75≥95% Pricing
AP10020Fmoc-Ala-Ala-Asn(Trt)-OH738.83 Pricing
AP10013Fmoc-Ala-Ala-Asn(Trt)-PAB843.96≥95% Pricing
AP10014Fmoc-Ala-Ala-Asn(Trt)-PAB-PNP1009.1≥95% Pricing
AP10004MC-Ala-Ala-Asn(Trt)-OH709.79≥98% Pricing